A Study to Evaluate Denosumab in Young Patients With Primary Breast Cancer

NCT01864798 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

27

Enrollment

OTHER

Sponsor class

Stopped Poor recruitment

Conditions

Breast Neoplasms

Interventions

DRUG: Denosumab

Sponsor

Jules Bordet Institute

Collaborators

[object Object]